|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Costs and expenses: | |||||
| Cost of Sales | |||||
| Selling, general and administrative expenses | |||||
| Research and development expenses | |||||
| Amortization of intangible assets | |||||
| Restructuring charges and certain acquisition and divestiture-related costs | |||||
| Interest expense, net of capitalized interest | |||||
| Other (income)/deductions––net | |||||
| Income before provision for taxes on income | |||||
| Provision for taxes on income | |||||
| Net income before allocation to noncontrolling interests | |||||
| Less: Net income/(loss) attributable to noncontrolling interests | |||||
| Net income attributable to Zoetis Inc. | |||||
| Earnings per share attributable to Zoetis Inc. stockholders: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted-average common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
| Dividends declared per common share |
Loading...
